Physician profile
Matthew S Hall
NPI 1356509319
$924.21
in general payments reported to CMS, 2019-2025
21 companies · $67.33 in 2025
The $67.33 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $84.76 · 2021: $212 · 2022: $95.83 · 2023: $22.71 · 2024: $74.66 · 2025: $67.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $247.91 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $162.15 | 2019-2025 | |
| Astellas Pharma US INC | $113.13 | 2019 | |
| Antares Pharma, INC. | $57.74 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $47.82 | 2019-2025 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $39.76 | 2019-2020 | |
| Aytu Biopharma, INC. | $26.68 | 2019-2020 | |
| Coloplast Corp | $24.49 | 2021 | |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Myriad Genetic Laboratories, INC. | $19.85 | 2021 | |
| Metuchen Pharmaceuticals | $19.61 | 2019 | |
| Neotract INC. | $15.18 | 2020 | |
| Amgen INC. | $15.01 | 2019 | |
| Dendreon Pharmaceuticals LLC | $14.85 | 2020 | |
| Zyla Life Sciences, INC. | $14.44 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.29 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $14.13 | 2025 | Bard Urinary Drainage Bag |
| Therapeuticsmd, INC. | $14.05 | 2019 | |
| Teleflex LLC | $14.00 | 2021 | |
| Janssen Biotech, INC. | $13.64 | 2019 | |
| Pfizer INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.